Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP933119.RAvh4vF4d7LclLXAF0aZd8NtPe5k1n5i_0D3dstkpKwCU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP933119.RAvh4vF4d7LclLXAF0aZd8NtPe5k1n5i_0D3dstkpKwCU130_assertion type Assertion NP933119.RAvh4vF4d7LclLXAF0aZd8NtPe5k1n5i_0D3dstkpKwCU130_head.
- NP933119.RAvh4vF4d7LclLXAF0aZd8NtPe5k1n5i_0D3dstkpKwCU130_assertion description "[This review discusses the most promising vaccination strategies for non-small cell lung cancer including the allogeneic tumor cell vaccine belagenpumatucel-L, which is a mixture of 4 allogeneic non-small cell lung cancer cell lines genetically modified to secrete an antisense oligonucleotide to transforming growth factor ?2 and 3 other target protein-specific vaccines designed to induce responses against melanoma-associated antigen A3, mucin 1, and epidermal growth factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP933119.RAvh4vF4d7LclLXAF0aZd8NtPe5k1n5i_0D3dstkpKwCU130_provenance.
- NP933119.RAvh4vF4d7LclLXAF0aZd8NtPe5k1n5i_0D3dstkpKwCU130_assertion evidence source_evidence_literature NP933119.RAvh4vF4d7LclLXAF0aZd8NtPe5k1n5i_0D3dstkpKwCU130_provenance.
- NP933119.RAvh4vF4d7LclLXAF0aZd8NtPe5k1n5i_0D3dstkpKwCU130_assertion SIO_000772 21952280 NP933119.RAvh4vF4d7LclLXAF0aZd8NtPe5k1n5i_0D3dstkpKwCU130_provenance.
- NP933119.RAvh4vF4d7LclLXAF0aZd8NtPe5k1n5i_0D3dstkpKwCU130_assertion wasDerivedFrom befree-20150227 NP933119.RAvh4vF4d7LclLXAF0aZd8NtPe5k1n5i_0D3dstkpKwCU130_provenance.
- NP933119.RAvh4vF4d7LclLXAF0aZd8NtPe5k1n5i_0D3dstkpKwCU130_assertion wasGeneratedBy ECO_0000203 NP933119.RAvh4vF4d7LclLXAF0aZd8NtPe5k1n5i_0D3dstkpKwCU130_provenance.